BIO announces Business Forum company presentations.
April 13, 2010 -
BIO announced the Business Forum company presentations will take place at 2010 BIO International Convention, scheduled for May 3-6. Presentations will provide insight to stories, pipelines, and partnering objectives of participating domestic and international companies in 35 therapeutic and industry tracks, including leading biotechnology and pharmaceutical companies, oncology, cardiology, CNS/neurology, diagnostics, gene/cell therapy, infectious diseases, and immunology.
Original Press release
Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
BIO Announces Business Forum Company Presentations at the 2010 BIO International Convention
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced the Business Forum company presentations to take place at the 2010 BIO International Convention. The global event for biotechnology will be held May 3-6 in Chicago, Ill. at McCormick Place.
Company presentations will provide valuable insight to the stories, pipelines, and partnering objectives of participating domestic and international companies in 35 different therapeutic and industry tracks, including leading biotechnology & pharmaceutical companies, oncology, cardiology, CNS/neurology, diagnostics, gene/cell therapy, infectious diseases and immunology.
"Currently, we have more than 130 companies scheduled to present at the BIO Business Forum, more than 40 percent of which are international," said Alan Eisenberg, Executive Vice President of Emerging Companies & Business Development at BIO. "Given the current economic climate, collaborations from the pharmaceutical and biotechnology sector are more important than ever. These presentations and networking opportunities can lead to future collaborations down the road, resulting in innovations in research, medicines and new technologies."
In addition to company presentations, BIO Business Forum attendees can schedule one-on-one meetings using BIO One-on-One Partnering(TM) and discuss potential business opportunities through numerous formal and informal networking opportunities. BIO currently expects more than 14,000 meetings among biotechnology and pharmaceutical companies, academic institutions, and investors from around the world. Many companies, including sanofi pasteur, have initiated partnerships after attending the BIO Business Forum.
"This event is a very important component of sanofi pasteur's partnering efforts," said Dr. Allan Jarvis, vice president of corporate development at sanofi pasteur. "This year we expect to be booked solid again in our partnering presentations. We believe that this is a great venue to develop successful partnerships to develop vaccines for global health."
Opportunities are still available for companies interested in presenting at the Business Forum at the 2010 BIO International Convention. Applications will be accepted until April 12, 2010. To request a presentation slot, visit: http://business-forum.bio.org/bf/2010/presentations/presentationapp.asp.
2010 Presenting Companies:
7TM Pharma A/S
Aastrom Biosciences Inc. (ASTM)
Addex Pharmaceuticals (SIX: ADXN)
Adolor Corp. (ADLR)
Affectis Pharmaceuticals AG
Allon Therapeutics Inc. (TSE: NPC)
Altea Therapeutics Corporation
Amarin Corp. PLC (AMRN)
Amylin Pharmaceuticals (AMLN)
Bavarian Nordic A/S (CPH: BAVA)
Bayer HealthCare (ETR: BAYN)
BiondVax Pharmaceuticals Ltd. (TASE: BNDX)
Bionomics Ltd (ASX: BNO)
BioSante Pharmaceuticals Inc. (BPAX)
Biovest International, Inc. (BVTI)
Boehringer Ingelheim GmbH
BTG PLC (LSE: BGC)
caprotec bioanalytics GmbH
Capstone Therapeutics (CAPS)
Cevec Pharmaceuticals GmbH
Champions Biotechnology (CSBR)
CombinatoRx Inc. (CRXX)
Cortex Pharmaceuticals Inc. (CORX)
Crown Bioscience Inc.
Diamyd Medical AB (STO: DIAM)
Elan Drug Technologies (ELN)
Eli Lilly (LLY)
Endocrine Technology, LLC
EpiCept Corporation (EPCT)
FivePrime Therapeutics, Inc.
Genfit (EPA: ALGFT)
Genta Inc. (GETA)
Golden biotechnology Corp.
HanAll Biopharma Co., Ltd. (SEO: 009420)
Hanmi Pharm. Co., Ltd. (SEO: 008930)
Hemispherx Biopharma, Inc. (HEB)
Idera Pharmaceuticals, Inc. (IDRA)
Immunovaccine Inc. (CVE: IMV)
Inovio Biomedical Corp. (INO)
Isis Pharmaceuticals (ISIS)
KMT Hepatech, Inc.
Lexicon Pharmaceuticals, Inc. (LXRX)
LG Life Sciences (SEO: 068870)
Light Sciences Oncology
Logical Therapeutics, Inc.
MDRNA Inc. (MRNA)
Medicago Inc. (MDCGF)
MethylGene Inc. (TSE: MYG)
Micromet Inc. (MITI)
MolMed S.p.A. (BIT: MLM)
Movetis NV (EBR: MOVE)
National Institutes of Health
NovaBay Pharmaceuticals, Inc. (NBY)
Novavax Inc. (NVAX)
Novo Nordisk (NVO)
Nuon Therapeutics, Inc.
Oxygen Biotherapeutics, Inc. (OXBT)
PAION AG (ETR: PA8)
PDS Biotechnology Corporation
Pluristem Therapeutics, Inc. (PSTI)
PolyMedix, Inc. (PYMX)
Protalix Biotherapeutics Inc. (PLX)
QRxPharma Limited (ASX: QRX)
Regado Biosciences, Inc.
RXI Pharmaceuticals Corp. (RXII)
Shionogi (TYO: 5407)
Spectrum Pharmaceuticals Inc. (SPPI)
Synergy Pharmaceuticals, Inc. (SGYP)
Takeda (TYO: 4502)
TenX Biopharma, Inc.
Transgenomic Inc. (TBIO)
University of Pittsburgh
Viralytics Ltd (ASX: VLA)
Viventia Biotechnologies, Inc
WuXi AppTec, Inc (WX)
Xenon Pharmaceuticals Inc.
YM BioSciences USA Inc. (YMI)
Zeltia S.A. (MCE: ZEL)
ZIOPHARM Oncology, Inc. (ZIOP)
Partnering for Global Health:
Aeras Global TB Vaccine Foundation
Bill & Melinda Gates Foundation
Drugs for Neglected Diseases initiative
Global Alliance for TB Drug Development
International AIDS Vaccine Initiative
Medicines for Malaria Venture
WHO Special Programme for Research and Training in Tropical Diseases (TDR)
Be included in official convention coverage - Tag your convention related content, blog posts, photos and videos with:
BIO International Convention: #bio10
BIO Business Forum: #bio1x1
BIO Exhibitors: #bioex
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.